NCT06997393

Brief Summary

This study aims to investigate the effect of a prevention programme on hand eczema among workers in the Greenlandic fishing industry. This is a non-randomised clinical trial including employees at four of Royal Greenland's fish processing facilities in Greenland.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

4 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 30, 2025

Completed
11 days until next milestone

Study Start

First participant enrolled

June 10, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

August 29, 2025

Status Verified

August 1, 2025

Enrollment Period

4 months

First QC Date

May 14, 2025

Last Update Submit

August 28, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change from baseline in knowledge of hand eczema at 3 months

    Knowledge of hand eczema measured by a self-reported questionnaire

    From enrollment to the end of intervention at 12 weeks

  • Change from baseline in clinical severity of hand eczema at 3 months

    Clinical severity of hand eczema measured by Hand Eczema Severity Index (HECSI). The HECSI score ranges from 0 to 360, with higher scores reflecting greater disease severity.

    From enrollment to the end of intervention at 12 weeks

Secondary Outcomes (5)

  • Change from baseline in patient-reported quality of life at 3 months

    From enrollment to the end of intervention at 12 weeks

  • Change from baseline in Patient Global Assessment of Disease Severity (PaGA) at 3 months

    From enrollment to the end of intervention at 12 weeks

  • Change from baseline in the number of self-reported days with absence from work due to hand eczema at 3 months

    From enrollment to the end of intervention at 12 weeks

  • Change from baseline in the number of participants being forced to change their job due to hand eczema at 3 months

    From enrollment to the end of intervention at 12 weeks

  • Change from baseline in the availability of protective equipment at 3 months

    From enrollment to the end of intervention at 12 weeks

Study Arms (2)

Prevention programme

EXPERIMENTAL

The participants will have access to a prevention programme.

Behavioral: Prevention programme

Control group

NO INTERVENTION

The participants will not have access to a prevention programme.

Interventions

The prevention programme consists of a validated educational video and training in the basic recognition and prevention of hand eczema.

Prevention programme

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Employee in Royal Greenland, a state-owned company and one of the largest seafood enterprises in the world
  • Written informed consent

You may not qualify if:

  • Age below 18 years
  • Inability to understand the Greenlandic, Danish or English language
  • Pregnancy
  • Other chronic skin diseases on the hands
  • Receiving immunomodulatory therapies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Royal Greenland

Ilulissat, Greenland

Location

Royal Greenland

Maniitsoq, Greenland

Location

Royal Greenland

Qasigiannguit, Greenland

Location

Royal Greenland

Sisimiut, Greenland

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 14, 2025

First Posted

May 30, 2025

Study Start

June 10, 2025

Primary Completion

October 1, 2025

Study Completion

December 1, 2025

Last Updated

August 29, 2025

Record last verified: 2025-08

Locations